Perspective: multimodality radionuclide therapy of progressive disseminated lymphoma and neuroendocrine tumors as a paradigm for cancer control.
Department of Nuclear Medicine, Fremantle Hospital, The University of Western Australia, Fremantle, Australia. harvey.turner@health.wa.gov.au
J Harvey
JH
Turner
D017326:Clinical Trials, Phase III as Topic; D018572:Disease-Free Survival; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D016499:Radioimmunotherapy; D011868:Radioisotopes / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D011868:Radioisotopes; D019275:Radiopharmaceuticals